A wide study of mRNA profiles from about two thousand tumours across 19 different cancer types showed PYCR1 as one of the most consistently overexpressed metabolic genes47, and its downregulation was found to reduce tumour growth and invasion capabilities, making cancer cells more susceptible to conventional chemotherapeutics.45 This evidence concerns the gene PYCR1 and neoplasm.